Key financial ranges
Market cap · USD equivalent−∞—+∞
P/E ratio−∞—+∞
Annual revenue · USD equivalent−∞—+∞
Revenue growth−∞—+∞
1,141–1,160 of 6,553
CompanyMarket capP/ERevenueRev. growthNet incomeCashDebtAI value
LTRNLantern Pharma Inc.$23.78M————$6.66M$39.72KAI pending
BLIVBeLive Holdings$23.9M—SGD 1.85M-40.2%-SGD 5.51MSGD 66.18KSGD 6.5KAI pending
SKKYSkkynet Cloud Systems, Inc.$23.91M—$2.55M-0.4%$35.35K$1.34M$0AI pending
AYTUAytu Biopharma, Inc$23.94M—$66.38M+1.8%-$13.56M$26.72M$12.53MAI pending
KMRKK-Tech Solutions Co Ltd$24.16M1,145.0×$16.16M-13.2%$171.41K$9.15M$994.59KAI pending
PVCTProvectus Biopharmaceuticals, Inc.$24.17M—$336.11K-45.5%-$5.43M$1.16M$103.9KOvervalued
LTSVLightstone Value Plus REIT IV, Inc.$24.3M—$30.54M+2.8%-$3.72M$10.94M$0AI pending
QNTMQuantum Biopharma Ltd.$24.46M————$1.91M$1.4MAI pending
APHDVerde Bio Holdings, Inc.$24.47M—$0-100.0%-$537.09K$11.56K$65.17KAI pending
MFMindForge Inc.$24.5M—$29.67M-42.5%-$2.72M$9.87M$397.29KAI pending
RNLXYRenalytix plc$24.53M—$2.29M+2,189.0%-$33.46M$909K$4.15MAI pending
TVRDTvardi Therapeutics, Inc.$24.61M—$7.14M-66.0%-$29.4M$15.77M$145KAI pending
FEMYFemasys Inc$24.62M—$2.29M+40.8%-$18.63M$1.44M$1.27MAI pending
MERCMercer International Inc.$24.66M—$1.87B-8.6%-$497.89M$78.78M$1.66BAI pending
ABVCAbvc Biopharma, Inc.$24.77M—$296K—-$7.91M$31.94K$1.82MOvervalued
ADTIAdapti, Inc.$24.86M—$13.67K-11.5%-$1.71M$32.77K$971.86KAI pending
GIPLGlobal Innovative Platforms Inc.$24.88M—$0—-$718.25K$244.24K$5.62KAI pending
NXPLNextPlat Corp$24.88M—$54.32M-17.8%-$10.46M$11.94M$1.58MAI pending
INVUInvestview, Inc.$24.9M—$36.26M-30.8%-$8.91M$1.99M$14.78KAI pending
GTECGreenland Technologies Holding Corp.$24.95M1.6×$90.69M+8.0%$4.93M$8.98M$1.52MAI pending